Latest news, reports, and more from the RedChip Nation.
 
Discovering Tomorrow's Blue Chips Today
December 16, 2020     Contact    
Latest News
 
Greenwich LifeSciences (NASDAQ: GLSI) Announces Poster Presentation of Five Year Data for GP2 Phase IIb Clinical Trial, Showing 0% Recurrence of Breast Cancer
 >
SPI Energy’s (NASDAQ: SPI) Closes Previously Announced $35.0 million Registered Direct Offering
 >
LMP Automotive (NASDAQ: LMPX) Engages Truist Securities, Inc. as the Lead Arranger for up to a $660M Syndicated Senior Credit Facilities
 
 
Aptorum Group (NASDAQ: APM) Announces Results of 2020 Annual General Meeting of Shareholders
 
 
Esports Entertainment’s (NASDAQ: GMBL) EGL to Manage Arsenal's Esports Team
 
 
Piedmont Lithium (NASDAQ: PLL) Announces Intent to Re-Domicile to United States
 
 
SinglePoint (OTC: SING) Outlines Strategic Initiatives to Secure Leadership Position in Renewable Energy Sector
 
 
 
Upcoming Zoom Calls
 

Join Zoom Meeting: https://zoom.us/j/91655325627
One tap mobile
+16465588656,,93709701316# US (New York)
+13017158592,,93709701316# US (Washington D.C)
Dial by your location
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Meeting ID: 916 5532 5627
International numbers available:
https://zoom.us/u/abqbFXqigE


 
 
 
 
 
Quote of the Week
 
"An investment in knowledge pays the best interest"
- Benjamin Franklin
 
 
 
Lesson of the Week
 
One of the hardest decisions small-cap investors face is knowing when and why to sell a stock.
Read More
 
 
 

 

Latest Videos
 
 
This Week on RedChip TV: 3 Top Stocks for 2021
 
This week on the RedChip Money Report, featured interviews with senior executives from RYU Apparel (OTC: RYPPF), SPI Energy (NASDAQ: SPI), and Annovis Bio (NYSE American: ANVS). Visit RedChip.com to learn more.
 
Watch Now
 
 
 
 
Annovis Bio: Potential Game Changer for Alzheimer’s Treatment
 
Annovis Bio (NYSE American: ANVS) is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Alzheimer’s in Down Syndrome (AD-DS). Annovis is believed to be the only company developing a drug for AD, PD and AD-DS that inhibits more than one neurotoxic protein and improves the information highway of the nerve cell, known as axonal transport.
 
Watch Now
 
 
 
 
Genius Group: Redefining Education in the 21st Century
 
Genius Group’s mission is to develop an entrepreneur education system that prepares students for the 21st Century. Led by founder Roger James Hamilton, a futurist and social entrepreneur, Genius Group is acquiring synergistic companies to strengthen its entrepreneur education curriculum, and in June 2020, Genius Group acquired Entrepreneur Resorts Limited for $32 million.
 
Watch Now
 
 
 
 
RYU: Award-Winning Urban Athletic Apparel Brand
 
RYU Apparel (OTC: RYPPF; TSX: RYU), or Respect Your Universe, is an award winning urban athletic apparel brand that engages in the development, marketing, and distribution of apparel, bags and accessories. RYU's Q1 and Q2 ecommerce revenue increased 80% over the same period last year, with Q3 and Q4 revenue projected to increase more than double that of 2019's ecommerce numbers.
 
Watch Now
 
 
 
 
Kiromic: The Intersection of Big Data Science and Immuno-Oncology
 
Kiromic BioPharma (NASDAQ: KRBP) is a target discovery and gene-editing company utilizing artificial intelligence and its proprietary neural network platform with a therapeutic focus on immuno-oncology. Visit KRBPinfo.com to learn more.
 
Watch Now
 
 
 
 
Better Choice: Rapidly Growing Pet Food Company
 
Better Choice Company (OTCQB: BTTR) is a rapidly growing animal health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier, and longer lives. Better Choice generated nearly $50 million in revenue in 2019 on a proforma basis that assumes its Q4 Halo acquisition closed on the first day of the year.
 
Watch Now
 
 
 
 
QuantGate Systems: Real-Time Market Participant Sentiment Platform
 
QuantGate Systems Inc. (OTC: QGSI) is a diversified fintech company engaged in researching, developing and deploying proprietary artificial intelligence trading platforms. The Company's unique approach, developed over 20 years of modelling and testing, utilizes radically innovative psychology-based models to quantify market participant sentiment and trader perception through real-time analysis of market participant activities.
 
Watch Now
 
 
 
 
Velodyne Lidar: Ushering in a New Era of Autonomous Technology
 
Watch RedChip’s exclusive interview with Velodyne Lidar (NASDAQ: VLDR) CEO Dr. Anand Gopalan. Velodyne Lidar is ushering in a new era of autonomous technology with the invention of real-time surround view lidar sensors. Velodyne is the first public pure-play lidar company and is known worldwide for its broad portfolio of breakthrough lidar technologies.
 
Watch Now
 
 
 
 
Red Cat CEO Discusses Acquisition of Fat Shark
 
Red Cat Holdings (OTC: RCAT) is developing a fully integrated drone supply chain with secure blockchain-based distributed storage, analytics and SaaS solutions for adoption in the drone industry. Red Cat supports education, training and sales of drone products through its Rotor Riot platform and is developing the means to accurately track, report and review flight data that will be useful for insurance and regulatory requirements.
 
Watch Now
 
 
 
 
Tiziana Life Sciences: Initiates COVID-19 Clinical Trial in Brazil
 
Tiziana Life Sciences (NASDAQ: TLSA) is a dual-listed UK biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology. In addition to Milciclib, the Company is also developing Foralumab for liver diseases. Foralumab is the only fully human anti-CD3 monoclonal antibody in clinical development in the world.
 
Watch Now
 
 
 
 
Genetic Technologies: Growing Pipeline of Next Generation Disease Risk Tests
 
Genetic Technologies (NASDAQ: GENE) is a diversified molecular diagnostics company. GENE offers cancer predictive testing and assessment tools to help physicians proactively manage patient health. The Company's lead products GeneType for Breast Cancer for non-hereditary breast cancer and GeneType for Colorectal Cancer are clinically validated risk assessment tests and are first in class.
 
Watch Now
 
 
 
 
BioVie: Launching Pivotal Phase 2b/3 Clinical Trial
 
BioVie Inc. (OTCQB: BIVI) is a clinical-stage company developing innovative drug therapies for liver disease. The Company’s drug candidate, BIV201 (continuous infusion terlipressin), has an Orphan Drug designation for the treatment of refractory ascites, FDA Fast Track status, and US patent pending. BIV201 also has an Orphan Drug designation for the treatment of hepatorenal syndrome (HRS).
 
Watch Now
 
 
 
 
OKYO Pharma: Next Generation Therapeutics for Eye Diseases and Chronic Pain
 
OKYO Pharma (OTCQB: EMMLF) is a biopharmaceutical company developing next generation therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. The Company is developing first in class drug candidates designed to prevent disease instead of controlling it.
 
Watch Now
 
 
 
 
1847 Goedeker: Leading Online Appliance Retailer Expecting $400M Sales in 2021
 
1847 Goedeker (NYSE American: GOED) is an industry leading e-commerce destination for appliances, furniture, and home goods. Since its founding in 1951, GOED has transformed from a local brick and mortar operation serving the St. Louis metro area to a respected nationwide omnichannel retailer that offers one-stop shopping for national and global brands. While GOED maintains its St. Louis showroom, over 90% of sales are placed through its website (www.goedekers.com).
 
Watch Now
 
 
 
 
LMP Automotive: Disrupting the Multi-Billion-Dollar Auto Industry
 
LMP Automotive Holdings (NASDAQ: LMPX) describes its business model as "Buy, Subscribe, Sell and Repeat." This means that we "Buy" pre-owned automobiles primarily through auctions or directly from other automobile dealers, and new automobiles from manufacturers and manufacturer distributors at fleet rates.
 
Watch Now
 
 
 
 
Milestone Scientific: Innovative Game-Changing Injection Technologies
 
Watch our exclusive interview with Dr. Giorgio Capogna, a key opinion leader in epidurals. In the interview, Dr. Capogna discusses the many advantages of Milestone Scientific’s (NYSE American: MLSS) innovative injection technologies when compared to current standards of care.
 
Watch Now
 
 
 
 
OLB Group: High-Growth Omni-Commerce and Payment Solutions Provider
 
The OLB Group (NASDAQ: OLB) is led by a team of seasoned industry executives with extensive experience in payments, ecommerce, and mobile commerce. The Company has developed and deploys a suite of integrated fintech and payment facilitation products and services that is a blend of Shopify (NASDAQ: SHOP) and Square (NYSE: SQ) with added features and benefits.
 
Watch Now
 
 
 
 
Nano Dimension: 3D Printing for Rapid Prototyping and Production of Electronics
 
Nano Dimension (NASDAQ: NNDM) is a provider of intelligent machines for the fabrication of Additively Manufactured Electronics (AME). High fidelity active electronic and electromechanical subassemblies are integral enablers of autonomous intelligent drones, cars, satellites, smartphones, and in vivo medical devices.
 
Watch Now
 
 
 
 
Medalist Diversified REIT: Strong Performance in Southeastern Markets
 
Medalist Diversified REIT (NASDAQ: MDRR) was founded in 2003 as a private equity company specializing in acquiring, owning, and managing commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns.
 
Watch Now
 
 
 
 
1847 Holdings: Acquisitions and Spinoffs of Growing US-Based Businesses
 
1847 Holdings LLC (OTCQB: EFSH) acquires and operates American companies it acquires at attractive valuations, leveraging its management team’s extensive experience gained at leading investment firms, such as Colony Capital, Lazard Freres and Saunders, Karp & Megrue, to grow operations and create value.
 
Watch Now
 
 
 
 
Recruiter.com CEO Interview: Revolutionizing the Recruiting Industry
 
Recruiter.com (OTCQB: RCRT) is a hiring platform for the world’s largest network of recruiters. Recruiter.com empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology.
 
Watch Now
 
 
 
 
Order Small Stocks, Big Money Today!
 
Dave Gentry is the author of Small Stocks, Big Money: Interviews With Microcap Superstars. Published by Wiley, this first-hand perspective on the fast world of microcap investing is now available for purchase.
 
 
MidSouth Week in Review
 
Household net worth rose to a record in Q3 as the value of stock portfolios and real estate surged.
Read More
 
 
 
 
About RedChip
 
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
 
RedChip Disclosure
 
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures.
 
 
     
 
 
Copyright © 2020 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.